Actelion Pharmaceuticals, Ltd
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$25.5M
Doctors Paid
190
Transactions
5,572
2024 Total
$96,394
Payment Breakdown by Category
Research$22.7M (88.8%)
Consulting$1.5M (5.7%)
Travel$1.2M (4.7%)
Food & Beverage$45,374 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $22.7M | 3,160 | 88.8% |
| Consulting Fee | $1.5M | 311 | 5.7% |
| Travel and Lodging | $1.2M | 934 | 4.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $167,691 | 45 | 0.7% |
| Food and Beverage | $45,374 | 1,122 | 0.2% |
Payments by Type
Research
$22.7M
3,160 transactions
General
$2.9M
2,412 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| DORMIR ADULTS - AC-078A201 | $8.5M | 0 | 232 |
| OPUS - AC-055-503 | $4.2M | 3 | 1,047 |
| AC-055-205 | $2.1M | 3 | 504 |
| TRITON | $1.8M | 0 | 265 |
| TRITON - AC-065A308 | $1.6M | 0 | 166 |
| OPsumit Users Registry | $1.4M | 2 | 307 |
| PORTICO | $784,664 | 1 | 146 |
| Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation | $661,855 | 0 | 195 |
| The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension | $461,698 | 0 | 104 |
| AC-055-403 - REPAIR | $367,257 | 0 | 56 |
| TRACE | $303,871 | 1 | 56 |
| AC-055-510 | $189,495 | 1 | 43 |
| AC-STUDY | $148,918 | 2 | 5 |
| MACI 577 SAD HQ - AC-080-101 | $124,483 | 0 | 2 |
| TPH1 | $17,447 | 0 | 1 |
| EVA-23906-00 Understanding Symptoms and Impacts Associated with Sarcoidosis Associated Pulmonary Hypertension (SAPH) and Evaluating the Pulmonary Arterial Hypertension. Symptoms and Impact (PAH SYMPACT) Measure among Patients with SAPH | $14,700 | 0 | 2 |
| 18-2587 Understanding Symptoms and Impacts Associated with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Evaluating the Pulmonary Arterial Hypertension. Symptoms and Impact (PAH SYMPACT) Measure among Patients with CTEPH | $10,112 | 0 | 3 |
| Understanding Symptoms and Impacts Associated with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Evaluating the Pulmonary Arterial Hypertension - Symptoms and Impact (PAH-SYMPACT) Measure among Patients with CTEPH | $10,100 | 0 | 3 |
| MS PHASE 2 EXTENSION HQ - AC-058B202 | $6,000 | 0 | 10 |
| NOT APPLICABLE | $5,900 | 2 | 2 |
| Understanding the Symptoms and Impacts Associated with Sarcoidosis-Associated Pulmonary Hypertension (SAPH) and Evaluating the Pulmonary Arterial Hypertension - Symptoms and Impact (PAHSYMPACT) Measure among Patients with SAPH | $4,250 | 0 | 1 |
| Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea | $4,250 | 1 | 1 |
| REPAIR Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension | $3,045 | 0 | 2 |
| AC-064A201-LUPUS | $2,250 | 2 | 2 |
| MERIT HQ - AC-055E201 | $1,800 | 1 | 1 |
| RUBATO - AC-055H301 | $311.85 | 4 | 4 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Willis Maddrey, Md, MD | Hepatology | Dallas, TX | $316,154 | $0 |
| Vallerie Mclaughlin, Md, MD | Internal Medicine | Ann Arbor, MI | $307,514 | $0 |
| Dr. Lewis Rubin, M.d, M.D | Internal Medicine | La Jolla, CA | $299,568 | $0 |
| Dr. Hyong Kim, M.d, M.D | Internal Medicine | La Jolla, CA | $262,304 | $0 |
| James Freston, M.d, M.D | Gastroenterology | Farmington, CT | $196,130 | $0 |
| Dr. Paul Watkins, Md, MD | Gastroenterology | Chapel Hill, NC | $156,028 | $0 |
| Dr. Richard Channick, M.d, M.D | Internal Medicine | Boston, MA | $137,677 | $0 |
| Ioana Preston, Md, MD | Critical Care Medicine | Burlington, MA | $112,373 | $0 |
| Robert Frantz, M.d, M.D | Cardiovascular Disease | Rochester, MN | $66,585 | $0 |
| Dr. Kelly Chin, M.d, M.D | Pulmonary Disease | Dallas, TX | $58,312 | $0 |
| Sonja Bartolome, M.d, M.D | Critical Care Medicine | Dallas, TX | $48,743 | $0 |
| Teresa De Marco, Md, MD | Internal Medicine | San Francisco, CA | $42,047 | $0 |
| Ronald Oudiz, M.d, M.D | Cardiovascular Disease | Torrance, CA | $37,940 | $0 |
| Victor Tapson, Md, MD | Allergy & Immunology | Los Angeles, CA | $35,864 | $0 |
| Dr. Nicholas Kim, M.d, M.D | Rheumatology | Anaheim, CA | $35,400 | $0 |
| Dr. Dinesh Khanna, M.d, M.D | Internal Medicine | Ann Arbor, MI | $32,649 | $0 |
| Dr. Anna Hemnes, Md, MD | Internal Medicine | Nashville, TN | $32,093 | $0 |
| Dr. Marc Simon, Md, MD | Specialist | San Francisco, CA | $31,194 | $0 |
| Paul Forfia, Md, MD | Cardiovascular Disease | Philadelphia, PA | $25,250 | $0 |
| Frank Hull, Md, MD | Critical Care Medicine | Plantation, FL | $23,400 | $0 |
| Adaani Frost, Md, MD | Pulmonary Disease | Houston, TX | $21,048 | $0 |
| Steven Nathan, Md, MD | Internal Medicine | Falls Church, VA | $20,013 | $0 |
| Jean Elwing, Md, MD | Internal Medicine | Cincinnati, OH | $19,168 | $0 |
| Ilia Segal, Md, MD | Critical Care Medicine | Union, NJ | $18,375 | $0 |
| Chad Miller, Md, MD | Pulmonary Disease | Austell, GA | $18,061 | $0 |
Ad
Top Products
- OPSUMIT MACITENTAN $5.1M
- OPSUMIT $2.9M
Associated Products (1)
- ZAVESCA MIGLUSTAT $15,380
Payment Categories
- Food & Beverage $45,374
- Consulting $1.5M
- Travel & Lodging $1.2M
- Research $22.7M
About Actelion Pharmaceuticals, Ltd
Actelion Pharmaceuticals, Ltd has made $25.5M in payments to 190 healthcare providers, recorded across 5,572 transactions in the CMS Open Payments database. In 2024, the company paid $96,394. The top product by payment volume is OPSUMIT MACITENTAN ($5.1M).
Payments were distributed across 34 medical specialties. The top specialty by payment amount is Internal Medicine ($1.2M to 30 doctors).
Payment categories include: Food & Beverage ($45,374), Consulting ($1.5M), Research ($22.7M), Travel & Lodging ($1.2M).
Actelion Pharmaceuticals, Ltd is associated with 1 products in the CMS Open Payments database.